Handelsbanken Fonder AB Sells 93,113 Shares of The Cooper Companies, Inc. $COO

Handelsbanken Fonder AB trimmed its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 57.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,947 shares of the medical device company’s stock after selling 93,113 shares during the period. Handelsbanken Fonder AB’s holdings in Cooper Companies were worth $5,733,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. New York Life Investment Management LLC grew its stake in Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after acquiring an additional 158 shares in the last quarter. Allworth Financial LP grew its stake in Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after acquiring an additional 167 shares in the last quarter. Mesirow Financial Investment Management Inc. grew its stake in Cooper Companies by 1.3% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock worth $961,000 after acquiring an additional 175 shares in the last quarter. Blue Trust Inc. grew its stake in Cooper Companies by 13.9% in the 4th quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock worth $124,000 after acquiring an additional 185 shares in the last quarter. Finally, Norden Group LLC grew its stake in Cooper Companies by 3.2% in the 4th quarter. Norden Group LLC now owns 6,634 shares of the medical device company’s stock worth $544,000 after acquiring an additional 205 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

NASDAQ COO opened at $62.55 on Friday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The firm’s 50 day moving average price is $66.92 and its 200-day moving average price is $75.14. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The company has a market cap of $12.20 billion, a PE ratio of 30.97, a P/E/G ratio of 1.62 and a beta of 0.89.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the prior year, the company posted $0.92 earnings per share. Cooper Companies’s revenue for the quarter was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Sell-side analysts forecast that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Citigroup dropped their target price on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a research note on Friday, March 6th. William Blair upgraded shares of Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Needham & Company LLC upped their target price on shares of Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research note on Friday, March 6th. Finally, Barclays upped their target price on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, March 6th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $90.79.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.